Cerebral infarction and cerebral bleeding
Conditions
Interventions
None listed
Sponsors
Kajikawa Hospital
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. A patient admitted to Kajikawa Hospital with cerebral bleeding or cerebral infarction diagnosed by the doctor 2. Patient within seven days from the onset of cerebrovascular event at the time of informed consent 3. Men and women at 20 years of age or more
Exclusion criteria
Exclusion criteria: 1. A subject under 20 years of age 2. A patient with hemodialysis 3. A patient who do not obtain approval from the legal representative or the person himself 4. A patient whom the doctor judged inappropriate for the enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlations between the pathophysiology of cerebrovascular diseases and concentrations of following biomarkers ; apolipoprotein B-48, remnant lipoprotein cholesterol(RemL-C), adiponectin and free fatty acids | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlations between concentrations of former biomarkers and following classical biomarkers ; blood cell count, total cholesterol, TG, HDL-C, LDL-C, fasting blood glucose, HbA1c, GOT, GPT, Cr, BUN, CCr, APTT, PT, fibrinogen, FDP, D-dimer, Urinary Albumin | — |
Countries
Japan
Contacts
Public ContactTomoya Mukai
Hiroshima University Hospital Department of Clinical Neuroscience and Therapeutics
Outcome results
None listed